Neda Nikolovski
Belgrade, SE, Serbia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
FFAR2 activation induces IL-22-dependent intestinal immune responses to suppress CNS autoimmunity.
Journal: EMBO molecular medicine
Published: January 20, 2026
Assessing Peripheral Blood Biomarkers and Predictive Patterns in Multiple Sclerosis Using Cytokines and Immune Gene Expression Profiles in Ocrelizumab-Treated Patients: Tracking Tumor Necrosis Factor.
Journal: International journal of molecular sciences
Published: September 30, 2025
IMMUnity Unveiled: A Translational NETwork for tackling PARKinson's Disease - IMMUPARKNET.
Journal: Open research Europe
Published: January 22, 2025
(Dys)regulation of the Immune System in Parkinson's Disease: Methodologies, Techniques, and Key Findings from Human Studies.
Journal: Aging and disease
Published: September 12, 2024
Immunomodulatory effects of HYCO-3, a dual action CO-releaser/Nrf2 activator.
Journal: Clinical and experimental immunology
Published: July 11, 2024
NRF2 Plays a Crucial Role in the Tolerogenic Effect of Ethyl Pyruvate on Dendritic Cells.
Journal: International journal of molecular sciences
Published: April 23, 2024
Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.
Journal: International journal of molecular sciences
Published: January 31, 2024
Complete Freund's adjuvant as a confounding factor in multiple sclerosis research.
Journal: Frontiers in immunology
Published: December 11, 2023
Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity.
Journal: Journal of neuroinflammation
Published: October 12, 2023
Ethyl pyruvate ameliorates acute respiratory distress syndrome in mice.
Journal: European journal of pharmacology
Published: May 24, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026